Moderna to charge $ 25- $ 37 for COVID-19 vaccine: CEO tells paper



FILE PHOTO: Coronavirus: On November 16, 2020, U.S. biotech company Moderna announced a COVID-19 vaccine that is 94.5% effective. Montreal, November 16, 2020./File Photo

FRANKFURT (Reuters) – Moderna will charge governments between $ 25 and $ 37 per dose of its COVID-19 vaccine candidate, depending on the quantity ordered, chief executive Stéphane Bancel told German weekly Welt am Sonntag (WamS).

“So our vaccine costs about the same as a flu shot, which is between $ 10 and $ 50,” he said.

On Monday, an EU official involved in the negotiations said the European Commission wanted to strike a deal with Moderna to supply millions of doses of its candidate vaccine at a price of less than $ 25 a dose.

“Nothing is signed yet, but we are close to concluding an agreement with the European Commission. We want to deliver to Europe and are in constructive talks, ”Bancel told WamS, adding that it was only a“ matter of days ”until a contract was ready.

Moderna said its investigational vaccine was 94.5% effective in preventing COVID-19, based on interim data from an advanced clinical trial, becoming the second developer to report results that far exceeded expectations after Pfizer and its partner BioNTech.

The EU has been in talks with Moderna for its experimental COVID-19 vaccine at least since July.

Reporting by Christoph Steitz; Editing by Mark Potter


Source link